TCA/GENETWORx Labs today unveiled a new breakthrough diagnostic Flu A-B/COVID-19/RSV combination test that provides patients with early detection of all three separate respiratory viruses with just one test sample.
Across the country, the coronavirus is exploding with over 13 million cases and President-Elect Joe Biden has warned of a “a very dark winter” with the virus and emphasized the need for more testing.
With people inside homes, businesses, and schools in cold weather months where there is less ventilation, the COVID-19 virus coupled with influenza and RSV (Respiratory Syncytial Virus) pose a formidable and unprecedented infectious disease threat, particularly since these viruses share similar symptoms. To help battle this triple threat, the new TCA/GENETWORx Combo PCR test provides patients the ability to detect strands of influenza A and B, RSV, and COVID-19 all from a single sample.
“If you are showing symptoms such as fever, cough, and shortness of breath, it’s important to know whether you or your loved one has COVID-19, influenza, or RSV. The only way to be sure is through diagnostic testing. With this new combination test, healthcare providers can provide an accurate diagnosis to patients and treat them with the appropriate measures. Patients then can observe appropriate quarantine measures to stop the spread.” – said William Miller, CEO of GENETWORx Labs
Read the full press release on GENETWORx Labs Launches New All-In-One Test that Detects COVID-19/Flu/RSV
